Results 271 to 280 of about 221,455 (333)

Toward Precision Oral Medicine in Pemphigus Vulgaris: A Conceptual AI Framework for Rituximab Response Prediction. [PDF]

Pharmaceuticals (Basel)
Russu EA, Ilinca R, Popa LG, Dumitriu AS, Păunică S, Giurcăneanu C, Albu CC.   +6 more
europepmc   +1 more source

Is shortening of corticosteroid duration feasible in paediatric warm autoimmune haemolytic anaemia? A single‐centre experience over 15 years

British Journal of Haematology, EarlyView.
Rafael Moisan, Stephany Gelin, Valérie Arsenault, Nancy Robitaille, Yves Pastore, Thomas Pincez   +5 more
wiley   +1 more source

Site-Specific Treatment and Remission Patterns in Multisite Mucous Membrane Pemphigoid.

JAMA Dermatol
McAleer L, La T, Li M, Cao JH, Dominguez AR.   +4 more
europepmc   +1 more source

Late-Onset Neutropenia After Rituximab in Multiple Sclerosis: Incidence, Predictors, and Outcomes in a Retrospective Multicenter Cohort. [PDF]

Neurol Neuroimmunol Neuroinflamm
Hallberg S, Kallin S, Evertsson B, Boremalm M, de Flon P, Salzer J, Lycke J, Fink K, Svenningsson A.   +8 more
europepmc   +1 more source

American Society of Hematology 2026 guidelines for immune thrombocytopenia: initial and second-line therapy for adults with primary ITP. [PDF]

Blood Adv
Cuker A, Terrell DR, Sowdagar H, Arnold DM, Audia S, Bussel JB, González-López TJ, Grace RF, Masias C, McCrae KR, Mitrovic M, Neunert C, Panch SR, Shah S, Shy B, VandeVelde J, Cines DB, Vesely SK.   +17 more
europepmc   +1 more source

Rituximab as Salvage Therapy in Difficult-to-Treat Autoimmune Hepatitis: A Prospective Case Series. [PDF]

Gastro Hep Adv
Lammert C, Blessing N, Arif M, Minnaganti D, Weber R, Green K, Vuppalanchi R, Chalasani N.   +7 more
europepmc   +1 more source